GI Flashcards

(43 cards)

1
Q

Acid Reducing Drugs

A
Antacids
- Mg and Al hydroxide
- CaCO3
- NaHCO3
H2 Antagonists
- Ranitidine
- Cimetidine
- Famotidine
- Nizatidine
Proton Pump Inhibitors
- Omeprazole
- Esomeprazole
- Lansoprazole
- Dexlansoprazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antacids

A
Mechanism:
- chemically neutralize acid that is present
Short lived
Use:
- occasional GERD or dyspesia
- discriminate chest pain MI vs acid reflux
Drugs:
MgOH
- diarrhea
- hyperMg in renal pts
AlOH 
- constipation
- hypophosphatemia
- decrease drug adsorption
CaCO3 - produce CO2 - belching/bloating
- constipation
- hyperCa
- kidney stones
- acid rebound
NaHCO3 - produce CO2 - belching/bloating
- systemic alkalosis in renal pts
- fluid retention - Na
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

H2 antagonists

A

Mechanism:
- prevent histamine induced activation of H release - block histamine binding H2 receptors on parietal cells, no cAMP production
- decrease proton and pepsin secretion in dose dependent manner
Use:
- heartburn and dyspesia, GERD
- added to PPI for nocturnal breakthrough
- stress ulcer prophylaxis
- peptic ulcer healing and zollinger-ellison syndrome, but prefer PPIs
Tachyphylaxis
Drugs:
Cimetidine
- large doses: inhibits cyp450
- antiandrogenic - gynecomastia and galactorrhea
- cardiovascular problems
- confusion in elderly
Ranitidine
Famotidine
Nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proton Pump Inhibitors

A

Mechanism:
- directly block parietal H-K ATPase to decrease H secretion into lumen, irreversible block
- needs conversion to sulfenamide via acid
Most effective when parietal cells create the most acid - take before meal, preferably before 1st meal of day
Don’t take with H2 blockers cuz need the acid
Use:
- peptic ulcer disease, GERD, reflux esophagitis
- H pylori with abx
- Zollinger Ellison syndrome
- IV form used for upper GI bleed to reduce need for intervention and reduce risk of rebleeding after intervention
Drugs:
Omeprazole
Lansoprazole
Dexlansoprazole
Pantoprazole
Esomeprazole
Adverse events:
- common: headache, abdominal pain, nausea, diarrhea, flatulence
- p450 metabolism so drug interactions (clopidogrel be aware)
- increased risk of GI infxns - check for C diff if pt has diarrhea
- increase risk of fracture
- increased risk of pneumonia
- risk of hypomagnesemia - check Mg levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mucosal Protectants

A

Bismuth Salts
Sucralfate
Misoprostol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bismuth Salts

A
Action:
- coats ulcers and inflamed areas
Use:
- gastroenteritis - symptoms of nausea, dyspepsia, diarrhea
- traveler's diarrhea prophylaxis
Side effects:
- black tongue and feces
- interactions with anticoagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sucralfate

A

Action:
- forms temporary coating on ulcers, protects them from acid and digestive enzymes
Take before meals
Use:
- stress ulcer prophylaxis (not much anymore)
- bile reflux gastritis and esophageal ulcers post variceal banding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Misoprostol

A
Prostaglandin E1 analog
Action:
- stimulates mucous production
- decreases acid secretion
Uses:
- induces labor
- use in pts with chronic NSAID use cuz of ulcer risk with reduced PGE1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GI motility agents

A
Erythromycin - Abx
Cholinomimetics
- bethanechol, neostigmine
Dopamine receptor antagonists
- metoclopramide, domperidone
Serotonin - metoclopramide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Erythromycin

A
Macrolide abx
Action:
- activates motilin receptors on smooth muscle of antrum and small intestine
Use:
- diabetic gastroperesis
Adverese events:
- tachyphylaxis
- QT prolongation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cholinomimetics

A
Neostigmine, Bethanechol
- increase GI motility big time
Use:
- Ogilive syndrome (IV)
Side effects:
- cholinergic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metoclopramide, Domperidone

A

Dopamine receptor antagonists - pre and post synaptic
Action:
- promote gastric/intestinal motility through Ach release
- increase gastric tone
- improve antroduodenal coordination
- accelerate gastric emptying
Side effects of metoclopramide:
- reversible: somnolence, feeling jittery, headache, diarrhea
- serious side effects: tardive dyskinesia, dystonia, neuroleptic malignant syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Laxatives

A
Bulk forming 
- Fiber - psyllium
Osmotic Agents
- Magnesium salts
- polyethylene glycol
- Lactulose
- PED
- milk of magnesia
Stimulants
- Bisocodyl
- Senna
- Castor oil
- Cascara
Stool Softeners
- Docusate
- Mineral Oil
Cl channel secretion 
- Lubiprostone
GC-C agonist
- Linaclotide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Psyllium, Polycarbophil

A
Fiber laxative
- Bulk laxatives
Action:
- form gels in the colon causing water retention and distention
- increase peristalsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Polyethylene glycol, Mg salts, milk of magnesia

A

Osmotic laxative
Action:
- draw H2O into intestinal lumen via osmosis resulting in softer/liquid stools and distension induced peristalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bisacodyl/Dulcolax, Senna

A

Stimulant laxative
Action:
- stimulates colonic smooth muscle and causes H2O accumulation in lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Docusate

A

Surfactant
Stool softener - laxative
Action:
- causes fat/H2O to mix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mineral oil

A

Lubrictant
Stool softener - laxative
Action:
- prevents H2O absorption by coating stool
Can inhibit absorption of fat-soluble vitamins

19
Q

Lubiprostone

A

Cl channel secretion laxative
Action:
- activates ClC-2 chloride channels, chloride secretion, Na follows and water follows

20
Q

Linaclotide

A

GC-C agonist laxative
Action:
- binds GC-C receptor, increases cGMP, increases Cl and bicarbonate secretion, therefore water
- activates CFTR

21
Q

Anti-diarrheal

A
Do not use if GI infxn or inflammation is present
- toxic megacolon
Antimotility
- Loperamide
- Diphenoxylate-atropine
- Tincture of opium
Absorbents
- Bismuth subsalicylate
- Fiber
- Bile acid binding resins - cholestryramine, colestipol
Antisecretory
- Octreotide
- Somatostatin
22
Q

Loperamide, Diphenoxylate/atropine, Tincture of Opium

A

Anti-diarrhea
Antimotility agents - opiates
Action:
- act on opioid receptor in gut
- act directly on circular and longitudinal intestinal muscles
- inhibit peristalsis and prolong transit time of material within gut
- increases viscosity since more time for contact
- diminishes fluid and electrolyte loss
- increases anal sphincter tone
Caution:
- do not combine loperamide and tincutre of opium with other CNS depressants cuz sedation and respiratory depression

23
Q

Bismuth busalicyclate

A
Anti-diarrhea
Absorbent
- anti-secretory
- anti-microbial
- anti-inflammatory
Caution:
- salicylate, so do not use with aspirin or anticoagulants cuz of blood thinning effect
- reye syndrome - do not use with viral infxn in children
24
Q

Fiber

A

Anti-diarrhea
Bulking agent - stool regulator
Action:
- absorbs intraluminla water and improves consistency of diarrhea

25
Cholestryramine, Colestipol
Anti-diarrhea Bile acid binding resins Action: - form non-absorbable complex with bile acids - bile acids stimulate colonic secretion, causing secretory diarrhea - bile acids absorbed in terminal ileum Caution: - seperate from other meds by 2 hrs cuz binds them
26
Ocreotide/somatostatin
Anti-diarrhea Antisecretory agent Action: - reduces fluid and electrolyte secretion by stomach and pancreas - mild antimolity effect - promotes intestinal electrolyte absorption - suppresses neuroendocrine tumor release of peptides that cause intestinal hypersecretion of electrolytes and water
27
Anti-nausea and emesis
``` Anticholinergic - scopolamine Antihistamine - meclizine, dimenhydrinate DA antagonist - prochlorperazine, promethazine 5HT antagonist - ondansetron, dolasetron, granisetron Cannabinoid - dronabinol Neurokinin antagonist - aprepitant ```
28
Scopolamine
``` Antiemetic Anticholinergic Action: - blocks Ach at M1 receptor Use: - prevents motion sickness - prevents chemo induced nausea Side effects: - anticholinergic: dry mouth, sedation, blurred vision, confusion, urinary retention ```
29
Meclizine, Dimenhydrinate
Antiemetic Antihistamine Action: - block H1 and has anticholinergic effects Use: - tx motion sickness - hyperemesis gravidarum Side effects: - sedating; meclizine less than dimenhydrinate - anticholinergic: dry mouth, sedation, blurred vision, confusion, urinary retention
30
Promethazine, Prochlorperazine
``` Antiemetic DA antagonist Action: - D2 receptor blocker, some anticholinergic effects Use: - prophylaxis preop; postop - motion sickness - toxic and metabolic induced nausea - migraine related nausea - hyperemesis gravidarum Side effects: - anticholinergic: dry mouth, sedation, blurred vision, confusion, urinary retention - sedation - extrapyramidal - tardive dyskinesia, pseudo-parkinsonism, acute dystonia - QT prolongation ```
31
Ondansetron, Dolasetron, Granisetron
``` Antiemetic 5HT antagonist Action: - act on vagal nerve terminals and chemoreceptor trigger zone, antagonize serotonin receptors Use: - multiple settings for antiemesis - chemotherapy induced nausea/vomit - migraine related nausea - postop nausea/vomit - hyperemesis gravidarum Side effects: - QT prolongation ```
32
Dronabinol (delta 9 THC)
``` Antiemetic Cannabinoid Action: - agonize CB1 receptor Use: - chemo induced nausea vomit - appetite stimulant in AIDS/HIV Side effects: - euphoria, paranoia, CNS depression, abuse potential ```
33
Aprepitant, Fosaprepitant
``` Antiemtic NK antagonist Action: - substance P/neurokinin I receptor antagonist Use: - prevention of acute and delayed chemo induced and post-op nausea/vomit - give before chemo or anesthesia Adverse events: - hiccups - fatigue - increased risk of infxn ```
34
Anti-inflammatories
Aminosalicylates - sulfasalazine, mesalamine, balsalazide, olsalazine Glucocorticoids - prednisone, methylprednisolone, budesonide Immunomodulators - methotrexate, 6MP/azathioprine Biologics - infliximab, adalimumab, certolizumab, natalizumab
35
Mesalamine, Balsalazide, Olsalazine
``` 5-Aminosalicylates Anti-inflammatory Active in colon 5-ASA is active component Use: UC and Crohn's Adverse events: - mild GI and headache occasionally - hypersensitivity rxns - pancreatitis, pneumonitis - paradoxical worsening of disease - chronic interstitial nephritis ```
36
Sulfasalazine
``` Aminosalicylate Anti-inflammatory Prodrug release in colon Use: UC and Crohn's Adverse events: - frequent GI (N/V), CNS and hematologic side effects - megaloblastic anemia, leukopenia - agranulocytosis - monitor for this - decreased folic acid absorption - treat with folic acid ```
37
Prednisone, methylprednisolone
``` Glucocorticoid Use: - induce remission in both UC and Crohn's - not maintenance - must be tapered off Adverse events: - muscle wasting - lipodystrophy - buffalo hump, abdominal fat - thinning of skin - moon facies - HTN - poor wound healing - osteoporosis - hyperglycemia - increased suspectibility to infxn ```
38
Budesonide
``` Non-systemic glucocorticoid - controlled ileal or colonic release High first pass metabolism in liver Use: - induction for Crohn's and UC - requires taper Smaller pts get more systemic effects Adverse events: - muscle wasting - lipodystrophy - buffalo hump, abdominal fat - thinning of skin - moon facies - HTN - poor wound healing - osteoporosis - hyperglycemia - increased suspectibility to infxn ```
39
6-MP, Azathiopurine
Purine antimetabolites - 6MP metabolized by TPMT, HPRT, and xanthine oxidase - HPRT to 6TGN - active metabolite - TPMT to 6-MMP - inactive metabolite Action: - inhibits nucleotide synthesis, decreases lymphocytes, decreases pro-inflammatory cytokine production Use: - maintenance of remssion in UC and Crohn's; 3 mo to reach therapeutic levels Adverse events: - leukopenia, thrombocytopenia from 6-TGN - hepatotoxicity from 6-MMP - infxn risk increased - increased risk of malignancy - avoid use with allopurinol
40
Methotrexate
``` Immunomodulator - folate anti-metabolite - inhibits dihydrofolate reductase - results in apoptosis of T cells Use: - maintenance of remission in Crohn's Adverse events: - hepatotoxicity - myelosuppression - interstitial lung disease - mucositis - teratogenic Give folic acid to all pts ```
41
anti-TNFa
``` mAb against TNF-a Use: - induction and maintenance of remission in Crohn's and UC Infliximab - UC and CD Adalimumab - UC and CD Certolizumab - CD only Adverse events: - infxn - screen for latent TB and hepatitis B - myelosuppression - increased risk of malignancy - psoriasis - drug induced lupus - dymyelination syndrome ```
42
Natalizumab
Anti-integrin - blocks leukocyte migration from blood vessels to sites of inflammation Adverse events: - Progressive multifocal leukoencephalopathy
43
Vedolizumab
Anti-integrin - gut specific - blocks leukocyte migration from blood vessels to sites of inflammation